ESC 365 - Will omics finally fulfil the promise of personalised medicine in pulmonary hypertension?

ESC Professional Premium Access

Will omics finally fulfil the promise of personalised medicine in pulmonary hypertension?

Session: Shaping the future management of pulmonary hypertension

Topic: Treatment

Speaker: Professor M. Wilkins (London, GB)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Professor Martin Wilkins

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

1 presentation

0 follower

3 more presentations in this session

Inclusion of the patient perspective in new trials in pulmonary hypertension

Speaker: Ms P. Ferrari (Brussels, BE)

Novel concepts in trial design: a trialist's view

Speaker: Professor M. Humbert (Le Kremlin-Bicetre, FR)

What is the state of the art of reverse remodelling strategies for the treatment of pulmonary arterial hypertension?

Speaker: Professor M. Delcroix (Leuven, BE)

Access the full session

Shaping the future management of pulmonary hypertension

Speakers: Professor M. Wilkins, Ms P. Ferrari, Professor M. Humbert, Professor M. Delcroix

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

novartis

Explore sponsored resources